Cart
sales@molnova.com
Compound Y-1
CAS No. 2379438-80-7
Compound Y-1( Novel NA Inhibitor )
Catalog No. M22267 CAS No. 2379438-80-7
Compound Y-1 is a novel neuraminidase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 56 | In Stock |
|
| 2MG | 30 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 84 | In Stock |
|
| 25MG | 164 | In Stock |
|
| 50MG | 251 | In Stock |
|
| 100MG | 370 | In Stock |
|
| 200MG | 523 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCompound Y-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCompound Y-1 is a novel neuraminidase inhibitor.
-
DescriptionCompound Y-1 is a novel neuraminidase inhibitor.
-
In VitroNeuraminidase-IN-1 has good inhibitory effect on the A/WSN/33H1N1 virus strains, with low toxicity and good druggability.
-
In Vivo——
-
SynonymsNovel NA Inhibitor
-
PathwayOthers
-
TargetOther Targets
-
Recptorneuraminidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2379438-80-7
-
Formula Weight——
-
Molecular Formula——
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (394.01 mM)
-
SMILESC1=CC(=C(C=C1C=NNC(=O)C2=CC(=CC(=C2)O)O)[N+](=O)[O-])O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yu R , Cheng L P , Li M , et al. Discovery of Novel Neuraminidase Inhibitors by Structure-Based Virtual Screening, Structural Optimization, and Bioassay[J]. ACS Medicinal Chemistry Letters, 2019, 10(12):1667-1673.
molnova catalog
related products
-
beta-estradiol 17-ac...
beta-estradiol 17-acetate is a metabolite of estradiol.
-
Mast cell degranulat...
Mast cell degranulating peptide (28-49) is a bee venom depolarizer that can improve the cGMP content of cerebellum tablets in mice.
-
Sodium Hydrogen Sulf...
Sodium Hydrogen Sulfide (hydrate) is, like nitric oxide, an important gaseous mediator that has significant effects on the immunological, neurological, cardiovascular and pulmonary systems of mammals.
